DIKUL - logo
E-viri
Celotno besedilo
Recenzirano
  • Process development for oxi...
    Brummund, Jan; Müller, Monika; Schmitges, Thomas; Kaluzna, Iwona; Mink, Daniel; Hilterhaus, Lutz; Liese, Andreas

    Journal of biotechnology, 09/2016, Letnik: 233
    Journal Article

    •Cofactor regeneration system using glucose dehydrogenase successfully implemented.•Addition of low surfactant and co-solvent amounts enhanced reaction performance.•Oxygen supply had major influence on STY and enzymatic process stability.•Coupling efficiency of ∼15% determined during the process under varied conditions.•Limited total turnover character of the P450 constituted main process restriction. Cytochrome P450 monooxygenases are a unique family of enzymes that are able to catalyze regio- and stereospecific oxidations for a broad substrate range. However, due to limited enzyme activities and stabilities, hydrophobicity of substrates, as well as the necessity of a continuous electron and oxygen supply the implementation of P450s for industrial processes remains challenging. Aim of this study was to point out key aspects for the development of an efficient synthesis concept for cytochrome P450 catalyzed oxidations. In order to regenerate the natural cofactor NADPH, a glucose dehydrogenase was applied. The low water soluble terpene α-ionone was used as substrate for the model reaction system. The studies reveal that an addition of surfactants in combination with low volumetric amounts of co-solvent can significantly increase substrate availability and reaction rates. Furthermore, these additives facilitated a reliable sampling procedure during the process. Another key factor for the process design was the oxygen supply. Based on various investigations, a bubble-aerated stirred tank reactor in batch mode represents a promising reactor concept for P450 oxidations. Main restriction of the investigated reaction system was the low process stability of the P450 monooxygenase, characterized by maximum total turnover numbers of ∼4100molα‐ionone/molP450.